End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.12 CNY | -0.86% | -2.26% | +9.98% |
May. 29 | Sirio Pharma Co., Ltd. Approves Cash Dividend for 2023 | CI |
Apr. 21 | Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 4.36B 601M | Sales 2025 * | 5.03B 694M | Capitalization | 6.87B 948M |
---|---|---|---|---|---|
Net income 2024 * | 399M 55.05M | Net income 2025 * | 488M 67.33M | EV / Sales 2024 * | 1.58 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.37 x |
P/E ratio 2024 * |
17.4
x | P/E ratio 2025 * |
14.2
x | Employees | 2,610 |
Yield 2024 * |
4.12% | Yield 2025 * |
4.8% | Free-Float | 27.38% |
1 day | -0.86% | ||
1 week | -2.26% | ||
Current month | -2.26% | ||
1 month | -9.37% | ||
3 months | +17.36% | ||
6 months | +9.98% | ||
Current year | +9.98% |
Managers | Title | Age | Since |
---|---|---|---|
Pei Qing Lin
CEO | Chief Executive Officer | 59 | 15-03-31 |
Fan Xia
DFI | Director of Finance/CFO | 41 | 23-02-15 |
Zhuang Min Yao
BRD | Director/Board Member | 54 | 15-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shi Ming Hu
BRD | Director/Board Member | 55 | 21-07-06 |
Gui Long Zhu
BRD | Director/Board Member | 60 | 21-07-06 |
Pei Qing Lin
CEO | Chief Executive Officer | 59 | 15-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 38.12 | -0.86% | 423,125 |
24-06-06 | 38.45 | -1.94% | 637,950 |
24-06-05 | 39.21 | -2.46% | 492,375 |
24-06-04 | 40.2 | +1.28% | 621,500 |
24-06-03 | 39.69 | +1.77% | 821,000 |
End-of-day quote Shenzhen S.E., June 06, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.98% | 948M | |
+10.73% | 7.96B | |
+5.95% | 7.66B | |
-0.58% | 5.88B | |
-6.11% | 3.72B | |
-13.21% | 3.47B | |
-15.49% | 1.16B | |
-26.41% | 1.12B | |
-11.42% | 905M | |
-13.08% | 831M |
- Stock Market
- Equities
- 300791 Stock